Upgrade to SI Premium - Free Trial

Quoin Pharmaceuticals, Ltd. (QNRX) Reports Q2 Loss of $3.24/sh

August 18, 2022 8:37 AM

Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q2 EPS of ($3.24), versus ($18.05) reported last year.

For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.

Categories

Earnings

Next Articles